|
1) Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991; 254: 1178-81
|
|
|
|
2) Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation. 2002; 106: 1640-5
|
|
|
|
|
|
3) Jang IK, Bouma BE, Kang DH, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol. 2002; 39: 604-9
|
|
|
|
|
|
4) Raffel OC, Tearney GJ, Gauthier DD, et al. Relationship between a systemic inflammatory marker, plaque inflammation, and plaque characteristics determined by intravascular optical coherence tomography. Arterioscler Vasc Biol. 2007; 27: 1820-7
|
|
|
|
|
|
5) Sawada T, Shite J, Garcia-Garcia HM, et al. Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J. 2008. In press
|
|
|
|
|
|
6) Grube E, Gerckens U, Buellesfeldt L, et al. Images in cardiovascular medicine. Intracoronary imaging with optical coherence tomography: a new high-resolution techonology providing striking visualization in the coronary artery. Circulation. 2002; 106: 2409-10
|
|
|
|
|
|
7) Lim VY, Buellesfeld L, Grube E. Optical coherence tomography imaging of thrombus protrusion through stent struts after stenting in acute coronary syndrome. Heart. 2006; 92: 409
|
|
|
|
|
|
8) Bouma BE, Tearney GJ, Yabushita H, et al. Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart. 2003; 89: 317-21
|
|
|
|
|
|
9) Regar E, Schaar J, Serruys PW. Acute recoil in sirolimus-eluting stent: real time, in vivo assessment with optical coherence tomography. Heart. 2006; 92: 123
|
|
|
|
|
|
10) Raffel OC, Hannan JC, Jang IK. Coronary stent malapposition as a result of post-stenotic aneurysm detected by optical coherence tomography. J Invasive Cardiol. 2006; 18: 561-2
|
|
|
|
|
|
11) Kume T, Akasaka T, Kawamoto T, et al. Visualization of neointimal formation by optical coherence tomography. Int Heart J. 2005; 46: 1133-6
|
|
|
|
|
12) Regar E, Beusekom HMM, Giessen WJ, et al. Optical coherence tomography findings at 5-year follow-up after coronary stent implantation. Circulation. 2005; 112: e345-6
|
|
|
|
|
|
13) Suzuki Y, Ikeno F, Yeung AC. Drug-eluting stent strut distribution: a comparison between Cypher and Taxus by optical coherence tomography. J Invasive Cardiol. 2006; 18: 111-4
|
|
|
|
|
|
14) Babapulle MN, Joseph L, Belisle P, et al. A hierarchical Bayesian meta-analysis of randomized clinical trails of drug-eluting stents. Lancet. 2004; 364: 583-91
|
|
|
|
|
|
15) McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet. 2004; 364: 1519-21
|
|
|
|
|
|
16) Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirilimus-eluting stent implantation. Serial intravascular ultrasound analysis from the SIRIUS trail. J Am Coll Cardiol. 2004; 43: 1959-63
|
|
|
|
|
|
17) Takano M, Inami S, Jang IK, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol. 2007; 99: 1033-8
|
|
|
|
|
|
18) Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. Eur Heart J. 2007; 28: 961-7
|
|
|
|
|
|
19) Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005; 112: 270-8
|
|
|
|
|
|
20) 松本大典, 志手淳也, 横山光宏. 左回旋枝慢性完全閉塞病変に対しシロリムス溶出性ステントを留置した一例. The Circulation Frontier. 2006; 10: 58-61
|
|
|
|
|
|
21) Terashima M, Ito T, Katoh O, et al. Relationship between stent apposition pattern and neointimal coverage after sirolimus-eluting stent implantation: analyis by optical coherence tomography imaging. J Am Coll Cardiol. 2006; 47: 13B
|
|
|
|
|
|
22) Smet BJGL, Zijlstra F. A look at drug eluting stent with optical coherence tomography (editorial comment). Eur Heart J. 2007; 28: 918-9
|
|
|
|
|
|
23) Gupta R, Raffel C, Jang IK. Severe intimal hyperplasia after sirolimus-eluting stent deployment: evaluation by optical coherence tomography. Heart. 2007; 93: 754
|
|
|
|
|
|
24) Tanigawa J, Barlis P, Mario CD. Do unapposed stent struts endothelialise？ In vivo demonstration with optical coherence tomography. Heart. 2007; 93: 378
|
|
|
|
|
|
25) Buellesfeld L, Lim V, Gerckens U, et al. Comparative endoluminal visualization of TAXUS crush-stenting at 9 months follow-up by intravascular ultrasound and optical coherence tomography. Z Kardiol. 2005; 94: 690-4
|
|
|
|
|
|
26) Shite J, Matsumoto D, Yokoyama M. Sirolimus-eluting stent fracture with thrombus, visualization by optical coherence tomography. Eur Heart J. 2006; 27: 1389
|
|
|
|
|
|
27) Sawada T, Shite J, Shinke T, et al. Persistent malapposition after implantation of sirolimus-eluting stent into intramural coronary hematoma: optical coherence tomography observations. Circ J. 2006; 70: 1515-9
|
|
|
|
|
|
28) Tanimoto S, Aoki J, Serruys PW, et al. Paclitaxel-eluting stent restenosis shows three-layer appearance by optical coherence tomography. EuroIntervention. 2006; 1: 484
|
|
|
|
|
|
29) Erbel R, Marino CD, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicenter trail. Lancet. 2007; 369: 1869-75
|
|
|
|
|
|
30) Barlis P, Tanigawa J, Mario CD. Coronary bioabsorbable magnesium stent: 15-month intravascular ultrasound and optical coherence tomography findings. Eur Heart J. 2007; 28: 2319
|
|
|
|
|
|
31) Kawase Y, Hoshino K, Yoneyama R, et al. In vivo volumetric analysis of coronary stent using optical coherence tomography with a novel balloon occlusion-flushing catheter: a comparison with intravascular ultrasound. Ultrasound in Med & Biol. 2005; 31: 1343-9
|
|
|
|
|
|
32) Negi N, Koto M, Shite J, et al. Accuracy and characteristics of optical coherence tomography -assessment using phantom model. Jpn J Interv Cardiol. 2007; 22: 362-6
|
|
|
|
|